Industry Research Reports
Home > Reports > Service & Software > Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-09-06
Pages: 105 Pages
Report ld: 4953439
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The North America Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Cell and Gene Therapy Supply Chain Solution include Cencora, Inc（World Courier）, QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, Biocair, time:matters, Mercury Business Services, Cardinal Health, CRYOPDP, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Cell and Gene Therapy Supply Chain Solution market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Cencora, Inc（World Courier）
- QuickStat
- Associated Couriers, LLC
- Central Pharma
- POLAR EXPRES
- Biocair
- time:matters
- Mercury Business Services
- Cardinal Health
- CRYOPDP
- Cryoport
- NMDP BioTherapies
- McKesson
- Excel Courier
- Almac
- BEAM Logistics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Courier Company Provided
- Hosted Logistics Company Provided
Segment by Application
- Biotech and Pharmaceutical Companies
- Hospitals
- Research Organizations
- Other
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cell and Gene Therapy Supply Chain Solution market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Hosted Logistics Company Provided in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cell and Gene Therapy Supply Chain Solution value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Courier Company Provided
1.2.3 Hosted Logistics Company Provided
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biotech and Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Research Organizations
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Supply Chain Solution Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Region (2020-2025)
2.4 Global Cell and Gene Therapy Supply Chain Solution Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Cell and Gene Therapy Supply Chain Solution Market Size and Prospective (2020-2031)
2.5.2 Europe Cell and Gene Therapy Supply Chain Solution Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size and Prospective (2020-2031)
2.5.4 Latin America Cell and Gene Therapy Supply Chain Solution Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Cell and Gene Therapy Supply Chain Solution Historic Market Size by Type (2020-2025)
3.2 Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Type (2026-2031)
3.3 Different Types Cell and Gene Therapy Supply Chain Solution Representative Players
4 Breakdown Data by Application
4.1 Global Cell and Gene Therapy Supply Chain Solution Historic Market Size by Application (2020-2025)
4.2 Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Cell and Gene Therapy Supply Chain Solution Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Cell and Gene Therapy Supply Chain Solution Players by Revenue (2020-2025)
5.1.2 Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Cell and Gene Therapy Supply Chain Solution Revenue
5.4 Global Cell and Gene Therapy Supply Chain Solution Market Concentration Analysis
5.4.1 Global Cell and Gene Therapy Supply Chain Solution Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Supply Chain Solution Revenue in 2024
5.5 Global Key Players of Cell and Gene Therapy Supply Chain Solution Head office and Area Served
5.6 Global Key Players of Cell and Gene Therapy Supply Chain Solution, Product and Application
5.7 Global Key Players of Cell and Gene Therapy Supply Chain Solution, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025)
6.1.2.2 North America Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025)
6.1.3.2 North America Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025)
6.2.2.2 Europe Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025)
6.2.3.2 Europe Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025)
6.4.2.2 Latin America Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025)
6.4.3.2 Latin America Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Cencora, Inc（World Courier）
7.1.1 Cencora, Inc（World Courier） Company Details
7.1.2 Cencora, Inc（World Courier） Business Overview
7.1.3 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Introduction
7.1.4 Cencora, Inc（World Courier） Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.1.5 Cencora, Inc（World Courier） Recent Development
7.2 QuickStat
7.2.1 QuickStat Company Details
7.2.2 QuickStat Business Overview
7.2.3 QuickStat Cell and Gene Therapy Supply Chain Solution Introduction
7.2.4 QuickStat Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.2.5 QuickStat Recent Development
7.3 Associated Couriers, LLC
7.3.1 Associated Couriers, LLC Company Details
7.3.2 Associated Couriers, LLC Business Overview
7.3.3 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Introduction
7.3.4 Associated Couriers, LLC Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.3.5 Associated Couriers, LLC Recent Development
7.4 Central Pharma
7.4.1 Central Pharma Company Details
7.4.2 Central Pharma Business Overview
7.4.3 Central Pharma Cell and Gene Therapy Supply Chain Solution Introduction
7.4.4 Central Pharma Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.4.5 Central Pharma Recent Development
7.5 POLAR EXPRES
7.5.1 POLAR EXPRES Company Details
7.5.2 POLAR EXPRES Business Overview
7.5.3 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Introduction
7.5.4 POLAR EXPRES Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.5.5 POLAR EXPRES Recent Development
7.6 Biocair
7.6.1 Biocair Company Details
7.6.2 Biocair Business Overview
7.6.3 Biocair Cell and Gene Therapy Supply Chain Solution Introduction
7.6.4 Biocair Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.6.5 Biocair Recent Development
7.7 time:matters
7.7.1 time:matters Company Details
7.7.2 time:matters Business Overview
7.7.3 time:matters Cell and Gene Therapy Supply Chain Solution Introduction
7.7.4 time:matters Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.7.5 time:matters Recent Development
7.8 Mercury Business Services
7.8.1 Mercury Business Services Company Details
7.8.2 Mercury Business Services Business Overview
7.8.3 Mercury Business Services Cell and Gene Therapy Supply Chain Solution Introduction
7.8.4 Mercury Business Services Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.8.5 Mercury Business Services Recent Development
7.9 Cardinal Health
7.9.1 Cardinal Health Company Details
7.9.2 Cardinal Health Business Overview
7.9.3 Cardinal Health Cell and Gene Therapy Supply Chain Solution Introduction
7.9.4 Cardinal Health Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.9.5 Cardinal Health Recent Development
7.10 CRYOPDP
7.10.1 CRYOPDP Company Details
7.10.2 CRYOPDP Business Overview
7.10.3 CRYOPDP Cell and Gene Therapy Supply Chain Solution Introduction
7.10.4 CRYOPDP Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.10.5 CRYOPDP Recent Development
7.11 Cryoport
7.11.1 Cryoport Company Details
7.11.2 Cryoport Business Overview
7.11.3 Cryoport Cell and Gene Therapy Supply Chain Solution Introduction
7.11.4 Cryoport Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.11.5 Cryoport Recent Development
7.12 NMDP BioTherapies
7.12.1 NMDP BioTherapies Company Details
7.12.2 NMDP BioTherapies Business Overview
7.12.3 NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Introduction
7.12.4 NMDP BioTherapies Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.12.5 NMDP BioTherapies Recent Development
7.13 McKesson
7.13.1 McKesson Company Details
7.13.2 McKesson Business Overview
7.13.3 McKesson Cell and Gene Therapy Supply Chain Solution Introduction
7.13.4 McKesson Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.13.5 McKesson Recent Development
7.14 Excel Courier
7.14.1 Excel Courier Company Details
7.14.2 Excel Courier Business Overview
7.14.3 Excel Courier Cell and Gene Therapy Supply Chain Solution Introduction
7.14.4 Excel Courier Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.14.5 Excel Courier Recent Development
7.15 Almac
7.15.1 Almac Company Details
7.15.2 Almac Business Overview
7.15.3 Almac Cell and Gene Therapy Supply Chain Solution Introduction
7.15.4 Almac Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.15.5 Almac Recent Development
7.16 BEAM Logistics
7.16.1 BEAM Logistics Company Details
7.16.2 BEAM Logistics Business Overview
7.16.3 BEAM Logistics Cell and Gene Therapy Supply Chain Solution Introduction
7.16.4 BEAM Logistics Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
7.16.5 BEAM Logistics Recent Development
8 Cell and Gene Therapy Supply Chain Solution Market Dynamics
8.1 Cell and Gene Therapy Supply Chain Solution Industry Trends
8.2 Cell and Gene Therapy Supply Chain Solution Market Drivers
8.3 Cell and Gene Therapy Supply Chain Solution Market Challenges
8.4 Cell and Gene Therapy Supply Chain Solution Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Cell and Gene Therapy Supply Chain Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Cell and Gene Therapy Supply Chain Solution Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Cell and Gene Therapy Supply Chain Solution Revenue Share by Region (2020-2025)
Table 6. Global Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Cell and Gene Therapy Supply Chain Solution Revenue Share Forecast by Region (2026-2031)
Table 8. Global Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Type (2020-2025)
Table 10. Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Application (2020-2025)
Table 15. Global Cell and Gene Therapy Supply Chain Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Cell and Gene Therapy Supply Chain Solution Application
Table 18. Global Cell and Gene Therapy Supply Chain Solution Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cell and Gene Therapy Supply Chain Solution Market Share by Players (2020-2025)
Table 20. Global Top Cell and Gene Therapy Supply Chain Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain Solution as of 2024)
Table 21. Ranking of Global Top Cell and Gene Therapy Supply Chain Solution Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cell and Gene Therapy Supply Chain Solution Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cell and Gene Therapy Supply Chain Solution, Headquarters and Area Served
Table 24. Global Key Players of Cell and Gene Therapy Supply Chain Solution, Product and Application
Table 25. Global Key Players of Cell and Gene Therapy Supply Chain Solution, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Company (2020-2025)
Table 29. North America Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Company (2020-2025)
Table 33. Europe Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Company (2020-2025)
Table 41. Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Size by Application (2020-2025) & (US$ Million)
Table 47. Cencora, Inc（World Courier） Company Details
Table 48. Cencora, Inc（World Courier） Business Overview
Table 49. Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Product
Table 50. Cencora, Inc（World Courier） Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 51. Cencora, Inc（World Courier） Recent Development
Table 52. QuickStat Company Details
Table 53. QuickStat Business Overview
Table 54. QuickStat Cell and Gene Therapy Supply Chain Solution Product
Table 55. QuickStat Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 56. QuickStat Recent Development
Table 57. Associated Couriers, LLC Company Details
Table 58. Associated Couriers, LLC Business Overview
Table 59. Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Product
Table 60. Associated Couriers, LLC Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 61. Associated Couriers, LLC Recent Development
Table 62. Central Pharma Company Details
Table 63. Central Pharma Business Overview
Table 64. Central Pharma Cell and Gene Therapy Supply Chain Solution Product
Table 65. Central Pharma Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 66. Central Pharma Recent Development
Table 67. POLAR EXPRES Company Details
Table 68. POLAR EXPRES Business Overview
Table 69. POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Product
Table 70. POLAR EXPRES Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 71. POLAR EXPRES Recent Development
Table 72. Biocair Company Details
Table 73. Biocair Business Overview
Table 74. Biocair Cell and Gene Therapy Supply Chain Solution Product
Table 75. Biocair Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 76. Biocair Recent Development
Table 77. time:matters Company Details
Table 78. time:matters Business Overview
Table 79. time:matters Cell and Gene Therapy Supply Chain Solution Product
Table 80. time:matters Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 81. time:matters Recent Development
Table 82. Mercury Business Services Company Details
Table 83. Mercury Business Services Business Overview
Table 84. Mercury Business Services Cell and Gene Therapy Supply Chain Solution Product
Table 85. Mercury Business Services Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 86. Mercury Business Services Recent Development
Table 87. Cardinal Health Company Details
Table 88. Cardinal Health Business Overview
Table 89. Cardinal Health Cell and Gene Therapy Supply Chain Solution Product
Table 90. Cardinal Health Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 91. Cardinal Health Recent Development
Table 92. CRYOPDP Company Details
Table 93. CRYOPDP Business Overview
Table 94. CRYOPDP Cell and Gene Therapy Supply Chain Solution Product
Table 95. CRYOPDP Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 96. CRYOPDP Recent Development
Table 97. Cryoport Company Details
Table 98. Cryoport Business Overview
Table 99. Cryoport Cell and Gene Therapy Supply Chain Solution Product
Table 100. Cryoport Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 101. Cryoport Recent Development
Table 102. NMDP BioTherapies Company Details
Table 103. NMDP BioTherapies Business Overview
Table 104. NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Product
Table 105. NMDP BioTherapies Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 106. NMDP BioTherapies Recent Development
Table 107. McKesson Company Details
Table 108. McKesson Business Overview
Table 109. McKesson Cell and Gene Therapy Supply Chain Solution Product
Table 110. McKesson Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 111. McKesson Recent Development
Table 112. Excel Courier Company Details
Table 113. Excel Courier Business Overview
Table 114. Excel Courier Cell and Gene Therapy Supply Chain Solution Product
Table 115. Excel Courier Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 116. Excel Courier Recent Development
Table 117. Almac Company Details
Table 118. Almac Business Overview
Table 119. Almac Cell and Gene Therapy Supply Chain Solution Product
Table 120. Almac Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 121. Almac Recent Development
Table 122. BEAM Logistics Company Details
Table 123. BEAM Logistics Business Overview
Table 124. BEAM Logistics Cell and Gene Therapy Supply Chain Solution Product
Table 125. BEAM Logistics Revenue in Cell and Gene Therapy Supply Chain Solution Business (2020-2025) & (US$ Million)
Table 126. BEAM Logistics Recent Development
Table 127. Cell and Gene Therapy Supply Chain Solution Market Trends
Table 128. Cell and Gene Therapy Supply Chain Solution Market Drivers
Table 129. Cell and Gene Therapy Supply Chain Solution Market Challenges
Table 130. Cell and Gene Therapy Supply Chain Solution Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy Supply Chain Solution Product Picture
Figure 2. Global Cell and Gene Therapy Supply Chain Solution Market Share by Type: 2024 VS 2031
Figure 3. Courier Company Provided Features
Figure 4. Hosted Logistics Company Provided Features
Figure 5. Global Cell and Gene Therapy Supply Chain Solution Market Share by Application: 2024 VS 2031
Figure 6. Biotech and Pharmaceutical Companies
Figure 7. Hospitals
Figure 8. Research Organizations
Figure 9. Other
Figure 10. Cell and Gene Therapy Supply Chain Solution Report Years Considered
Figure 11. Global Cell and Gene Therapy Supply Chain Solution Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cell and Gene Therapy Supply Chain Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Latin America Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Cell and Gene Therapy Supply Chain Solution Market Share by Players in 2024
Figure 20. Global Top Cell and Gene Therapy Supply Chain Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain Solution as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Supply Chain Solution Revenue in 2024
Figure 22. North America Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
Figure 23. North America Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
Figure 24. Europe Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
Figure 25. Europe Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
Figure 26. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
Figure 27. Asia-Pacific Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
Figure 28. Latin America Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
Figure 29. Latin America Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
Figure 30. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Share by Type (2020-2025)
Figure 31. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Market Share by Application (2020-2025)
Figure 32. Cencora, Inc（World Courier） Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 33. QuickStat Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 34. Associated Couriers, LLC Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 35. Central Pharma Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 36. POLAR EXPRES Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 37. Biocair Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 38. time:matters Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 39. Mercury Business Services Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 40. Cardinal Health Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 41. CRYOPDP Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 42. Cryoport Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 43. NMDP BioTherapies Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 44. McKesson Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 45. Excel Courier Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 46. Almac Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 47. BEAM Logistics Revenue Growth Rate in Cell and Gene Therapy Supply Chain Solution Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cell and Gene Therapy Supply Chain Solution market?
The top companies in the global Cell and Gene Therapy Supply Chain Solution market are Cencora, Inc（World Courier）、QuickStat、Associated Couriers, LLC.
Related Reports
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 146
USD 4900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 107
USD 4250.00
(Single User License)
Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 130
USD 3950.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2026
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 130
USD 2900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 155
USD 4900.00
(Single User License)
Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 129
USD 3950.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 91
USD 2900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-12
Pages: 93
USD 2900.00
(Single User License)
Global and United States Cell and Gene Therapy Supply Chain Solution Market Report & Forecast 2024-2030
The global Cell and Gene Therapy Supply Chain Solution revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-12
Pages: 128
USD 4350.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Insights, Forecast to 2030
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-07-12
Pages: 156
USD 4900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 146
USD 4900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 107
USD 4250.00 (Single User License)Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 130
USD 3950.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2026
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 130
USD 2900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 155
USD 4900.00 (Single User License)Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 129
USD 3950.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 91
USD 2900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-12
Pages: 93
USD 2900.00 (Single User License)Global and United States Cell and Gene Therapy Supply Chain Solution Market Report & Forecast 2024-2030
The global Cell and Gene Therapy Supply Chain Solution revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-12
Pages: 128
USD 4350.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Insights, Forecast to 2030
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-07-12
Pages: 156
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now